How Can We Distinguish Sorafenib-Associated Skin Rash From Skin Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem-Cell Transplantation?

J Clin Oncol. 2021 Apr 20;39(12):1412. doi: 10.1200/JCO.20.02228. Epub 2021 Feb 23.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Exanthema* / chemically induced
  • Exanthema* / diagnosis
  • Graft vs Host Disease* / diagnosis
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Sorafenib / adverse effects
  • Transplantation, Homologous

Substances

  • Sorafenib